<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Systemic sclerosis (scleroderma) and pregnancy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Systemic sclerosis (scleroderma) and pregnancy</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Systemic sclerosis (scleroderma) and pregnancy</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bonnie L Bermas, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John S Axford, DSc, MD, FRCP, FRCPCH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Charles J Lockwood, MD, MHCM</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Philip Seo, MD, MHS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 03, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Systemic sclerosis (SSc; scleroderma) is an uncommon illness with an annual incidence of 1 to 2 per 100,000 individuals in the United States and a peak onset between the ages of 30 and 50 [<a href="#rid1">1,2</a>]. (See  <a class="medical medical_review" href="/d/html/7539.html" rel="external">"Clinical manifestations and diagnosis of systemic sclerosis (scleroderma) in adults"</a>.)</p><p>Literature on pregnancy in women with SSc was previously scarce, as most cases of this disorder occur in women past their peak reproductive years. However, as a greater number of women are choosing to have children well into their thirties and forties, the incidence of pregnancy in women with SSc is increasing.</p><p>This topic will review issues of fertility and pregnancy outcome among patients with SSc, as well as the impact of pregnancy upon disease activity.</p><p class="headingAnchor" id="H2"><span class="h1">FERTILITY</span><span class="headingEndMark"> — </span>In early reports from the 1950s, women with SSc were thought to have diminished fertility because of the low incidence of pregnancy in those with preexisting disease [<a href="#rid3">3</a>]. Subsequent studies, however, showed mixed results with respect to pregnancy rates and to the frequency of pregnancy difficulties among women with SSc, both prior to and after the diagnosis.</p><p>The following findings were noted in different observational studies of women with SSc who were of childbearing age:</p><p class="bulletIndent1"><span class="glyph">●</span>A retrospective analysis of reproductive events prior to the diagnosis of SSC reported a nonsignificant threefold increase in risk of the combined endpoint of infertility and spontaneous abortion compared with controls [<a href="#rid4">4</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A higher incidence of infertility and a longer time to conceive prior to the diagnosis of SSC compared with healthy controls (odds ratio 2.3 and 2.6, respectively), but not compared with women with primary Raynaud phenomenon [<a href="#rid5">5</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Significantly more live births prior to the onset of SSc and significantly fewer live births after the onset of SSC compared with women in the general population [<a href="#rid6">6</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>No difference in fertility among women with SSc compared with patients with rheumatoid arthritis and compared with healthy controls [<a href="#rid7">7</a>]</p><p></p><p>The conclusions that can be drawn from these studies are limited by their reliance upon patient recall and by a failure to usually distinguish whether women had difficulty conceiving or did not desire pregnancy.</p><p class="headingAnchor" id="H3"><span class="h1">SPONTANEOUS ABORTION</span><span class="headingEndMark"> — </span>Compared with the information available concerning systemic sclerosis (SSc) and fertility, somewhat more conclusive data have been published relating to the rate of spontaneous abortion in women who become pregnant prior to an eventual diagnosis of SSc. Multiple studies (but not all) suggest that such women have an increased risk [<a href="#rid4">4,8,9</a>]. As an example, the rate of spontaneous miscarriage among pregnant women, both prior to and subsequent to a diagnosis of SSc, was assessed in one study of 14 patients [<a href="#rid8">8</a>]. The rate of spontaneous miscarriage was significantly higher among those who became pregnant prior to disease diagnosis when compared with control individuals (22 versus 14 percent). Pregnant patients with preexisting SSc also had a significantly increased rate of spontaneous abortions. A similar risk (relative risk 2.1) was noted in another report of nearly 270 women with SSc [<a href="#rid4">4</a>]. In contrast to these findings, a third study found an increased number of medically induced (but not spontaneous) abortions among patients who became pregnant after disease onset, compared with controls [<a href="#rid9">9</a>]. A 2020 meta-analysis found an increased odds ratio of 1.6 (CI 95% 1.22-2.22) of miscarriage amongst women with SSc compared with the general obstetric population [<a href="#rid10">10</a>].</p><p>Thus, miscarriage appears to be more common among those women who go on to develop SSc, but it remains unclear whether spontaneous abortions occur more frequently among those already diagnosed with the disorder. Whether a history of a spontaneous abortion may predispose a woman to subsequently develop SSc is unknown [<a href="#rid4">4</a>]. Data concerning the spontaneous abortion rate among patients with a preexisting diagnosis of SSc are also clouded by the paucity of information regarding medication use during pregnancy [<a href="#rid11">11</a>].</p><p class="headingAnchor" id="H4"><span class="h1">PREGNANCY OUTCOME</span><span class="headingEndMark"> — </span>Although women with systemic sclerosis (SSc) typically have successful pregnancies, clinicians should be aware that there may be an increased risk of pregnancy complications:</p><p class="bulletIndent1"><span class="glyph">●</span>In a meta-analysis including observational data from articles on SSc and pregnancy outcomes published between 1950 and 2018, pregnancies in women with SSc had a higher risk of miscarriages, intrauterine growth restriction, preterm deliveries, and newborns with low birth weight compared with healthy controls [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In one study, prospectively collected data on 99 women who had 109 births were compared with the general obstetric population (total of 3,939 deliveries) [<a href="#rid12">12</a>]. SSc patients had a significantly increased frequency of preterm delivery, intrauterine growth restriction, and low-birthweight babies. A multivariable analysis showed that corticosteroid use was associated with preterm deliveries, whereas the use of <a class="drug drug_general" data-topicid="8475" href="/d/drug information/8475.html" rel="external">folic acid</a> and the presence of anti-Scl-70 may be protective. However, this study is limited because of the relatively few number of pregnancies in the scleroderma group.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another study compared outcomes in women with SSc with those in women with rheumatoid arthritis (RA) and in control individuals [<a href="#rid9">9</a>]. A nonsignificant trend toward an increased rate of premature births among patients with SSc, compared with the other two groups, was observed. In addition, there was an increased incidence of infants small for gestational age born to women with SSc, but there was no statistically significant increase in fetal death [<a href="#rid9">9,13</a>]. An expanded study by the same group of investigators retrospectively obtained reproductive histories in 214 women with SSc and compared them with 167 women with RA and with 105 neighborhood controls [<a href="#rid7">7</a>]. The patients with SSc had more premature births and more infants small for gestational age after disease onset. However, these results are limited because the effects of age and medication use on these results were not analyzed. Immunosuppressive agents used in patients with SSc, including <a class="drug drug_general" data-topicid="9809" href="/d/drug information/9809.html" rel="external">prednisone</a>, may cause premature rupture of the membranes, as well as infants small for gestational age [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a cross-sectional study of 342 patients with SSC, compared with the healthy control population, adverse pregnancy outcomes (including preterm infants, low birth weight infants, and cesarean sections) were increased in the SSc pregnancies [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In one study of 38 pregnancies in 26 female patients with active and or early disease, of the 33 live births, 60 percent had intrauterine growth restriction and low birth weight [<a href="#rid15">15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Using the National Inpatient Sample (NIS) database from 2000 to 2017, the authors reported on 3740 delivery associated hospitalizations in women with SSc. Throughout this time period, the risk of adverse pregnancy outcomes (including fetal death, preterm delivery, hypertensive disorders, intrauterine growth restriction) was statistically significantly higher amongst SSc women compared with the general obstetric population. While fetal death rates improved over time, there was no decline in other adverse pregnancy outcomes [<a href="#rid16">16</a>]. (See  <a class="medical medical_review" href="/d/html/7998.html" rel="external">"Safety of rheumatic disease medication use during pregnancy and lactation"</a>.)</p><p></p><p>There have been several case reports of SSc involving the cervix and perineum [<a href="#rid17">17,18</a>]. In this setting, vaginal delivery can be difficult, and elective cesarean delivery may be required.</p><p class="headingAnchor" id="H5"><span class="h1">IMPACT OF PREGNANCY UPON DISEASE ACTIVITY</span><span class="headingEndMark"> — </span>Although the data are limited, pregnancy does not clearly exacerbate systemic sclerosis (SSc) [<a href="#rid9">9,19</a>]. While there are case reports of poor pregnancy outcomes in women with SSc, in one large study that included 99 women with SSC who had 109 births, the disease remained stable in most patients [<a href="#rid12">12</a>]. There were four cases of disease progression which occurred within one year of delivery. All of these women were anti-Scl-70 positive, and three of them had a disease duration of less than three years. By contrast, the Canadian Scleroderma research group reported on 45 women who became pregnant after their diagnosis of SSc and compared them with 153 SSc women who were nulliparous. Disease progression including pulmonary, kidney, and physician global assessment was not different between these two groups [<a href="#rid20">20</a>].</p><p class="headingAnchor" id="H6"><span class="h2">SSc renal crisis</span><span class="headingEndMark"> — </span>Kidney disease is common in patients with SSc [<a href="#rid21">21</a>] (see  <a class="medical medical_review" href="/d/html/7183.html" rel="external">"Kidney disease in systemic sclerosis (scleroderma), including scleroderma renal crisis"</a>). In the pregnant patient, however, it is extremely difficult to distinguish kidney dysfunction due to SSc from that resulting from preeclampsia and eclampsia. One review of the literature, for example, found that seven of nine patients initially thought to have preeclampsia actually had kidney biopsy findings more consistent with SSc kidney disease [<a href="#rid22">22</a>] (see  <a class="medical medical_review" href="/d/html/6814.html" rel="external">"Preeclampsia: Clinical features and diagnosis"</a>). Another possible differential in the postpartum period is hemolytic-uremic syndrome; this disorder <strong>cannot</strong> be distinguished histologically from SSc kidney. (See  <a class="medical medical_review" href="/d/html/7237.html" rel="external">"Acute kidney injury in pregnancy"</a>.)</p><p>Whether pregnancy is associated with an increased incidence of renal crisis among patients with preexisting SSc is unclear. One study of women with SSc found no enhanced incidence of renal crisis in pregnant women when compared with those who did not become pregnant [<a href="#rid9">9</a>].</p><p>An extremely high morbidity and mortality has been observed among those who develop renal crisis during pregnancy [<a href="#rid13">13</a>]. The use of angiotensin-converting enzyme (ACE) inhibitors was beneficial in one case report, but ACE inhibitors are contraindicated during pregnancy because of the risk to the fetus [<a href="#rid23">23,24</a>] (see  <a class="medical medical_review" href="/d/html/4789.html" rel="external">"Adverse effects of angiotensin converting enzyme inhibitors and receptor blockers in pregnancy"</a>). However, in the case of renal crisis during pregnancy, ACE inhibitors may be necessary to control disease, and patients should be counseled accordingly regarding the risk of these medications during pregnancy. Thus, patients with SSc and active kidney disease should be counseled regarding the high morbidity and mortality associated with pregnancy.</p><p class="headingAnchor" id="H7"><span class="h1">OTHER CONSIDERATIONS</span><span class="headingEndMark"> — </span>Difficulties in delivery secondary to skin fibrosis and the aggravation of relatively minor symptoms may also occur among pregnant patients with systemic sclerosis (SSc). As an example, the increased abdominal pressure in pregnancy may exacerbate dyspepsia due to esophageal dysmotility. Some symptoms, however, may diminish; symptoms of Raynaud phenomenon generally lessen because of the vasodilatation of pregnancy [<a href="#rid22">22</a>].</p><p class="headingAnchor" id="H3176587639"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/118282.html" rel="external">"Society guideline links: Systemic sclerosis (scleroderma)"</a>.)</p><p class="headingAnchor" id="H25040535"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fertility</strong> – It is difficult to draw clear conclusions concerning fertility in women with systemic sclerosis (SSc) due to the very limited data that are available. Studies have shown mixed results with respect to pregnancy rates and to the frequency of pregnancy difficulties among women with SSc, both prior to and after the diagnosis. (See <a class="local">'Fertility'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Spontaneous abortion</strong> – Multiple studies (but not all) suggest that women who become pregnant prior to an eventual diagnosis of SSc have an increased risk of spontaneous abortion. There are some data to suggest that pregnancy after the diagnosis of SSc is associated with higher miscarriage rate. (See <a class="local">'Spontaneous abortion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pregnancy outcomes</strong> – Although women with SSc typically have successful pregnancies, clinicians should be aware that there may be an increased risk of pregnancy complications including an increased risk of premature births and of infants small for gestational age after disease onset; however, the impact of medication use, age, and other risk factors for prematurity on these results is not known. (See <a class="local">'Pregnancy outcome'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impact of pregnancy on SSc</strong> – Although the data are limited, pregnancy does not clearly exacerbate SSc. However, extremely high morbidity has been observed among those who develop renal crisis during pregnancy, and patients with SSc and active kidney disease should be counseled regarding the high morbidity and mortality associated with pregnancy. (See <a class="local">'Impact of pregnancy upon disease activity'</a> above and <a class="local">'SSc renal crisis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impact of pregnancy on Raynaud phenomenon</strong> – Symptoms of Raynaud phenomenon generally lessen during pregnancy because of vasodilatation. However, difficulties in delivery secondary to skin fibrosis and the aggravation of relatively minor symptoms, such as dyspepsia, may occur among pregnant patients with SSc. (See <a class="local">'Other considerations'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Medsger TA Jr, Masi AT. Epidemiology of progressive systemic sclerosis. Clin Rheum Dis 1979; 5:15.</a></li><li><a class="nounderline abstract_t">Sánchez-Guerrero J, Colditz GA, Karlson EW, et al. Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med 1995; 332:1666.</a></li><li><a class="nounderline abstract_t">LEINWAND I, DURYEE AW, RICHTER MN. Scleroderma; based on a study of over 150 cases. Ann Intern Med 1954; 41:1003.</a></li><li><a class="nounderline abstract_t">Silman AJ, Black C. Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a controlled study. Ann Rheum Dis 1988; 47:441.</a></li><li><a class="nounderline abstract_t">Englert H, Brennan P, McNeil D, et al. Reproductive function prior to disease onset in women with scleroderma. J Rheumatol 1992; 19:1575.</a></li><li><a class="nounderline abstract_t">Bernatsky S, Hudson M, Pope J, et al. Assessment of reproductive history in systemic sclerosis. Arthritis Rheum 2008; 59:1661.</a></li><li><a class="nounderline abstract_t">Steen VD, Medsger TA Jr. Fertility and pregnancy outcome in women with systemic sclerosis. Arthritis Rheum 1999; 42:763.</a></li><li><a class="nounderline abstract_t">Giordano M, Valentini G, Lupoli S, Giordano A. Pregnancy and systemic sclerosis. Arthritis Rheum 1985; 28:237.</a></li><li><a class="nounderline abstract_t">Steen VD, Conte C, Day N, et al. Pregnancy in women with systemic sclerosis. Arthritis Rheum 1989; 32:151.</a></li><li><a class="nounderline abstract_t">Blagojevic J, AlOdhaibi KA, Aly AM, et al. Pregnancy in Systemic Sclerosis: Results of a Systematic Review and Metaanalysis. J Rheumatol 2020; 47:881.</a></li><li><a class="nounderline abstract_t">Bermas BL, Hill JA. Effects of immunosuppressive drugs during pregnancy. Arthritis Rheum 1995; 38:1722.</a></li><li><a class="nounderline abstract_t">Taraborelli M, Ramoni V, Brucato A, et al. Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study. Arthritis Rheum 2012; 64:1970.</a></li><li><a class="nounderline abstract_t">Steen VD. Scleroderma and pregnancy. Rheum Dis Clin North Am 1997; 23:133.</a></li><li><a class="nounderline abstract_t">Dai L, Xu D, Li X, et al. Reproductive health in female patients with systemic sclerosis: a cross-sectional study. Rheumatology (Oxford) 2023.</a></li><li><a class="nounderline abstract_t">Braun J, Balbir-Gurman A, Toledano K, et al. Favourable outcome of planned pregnancies in systemic sclerosis patients during stable disease. Scand J Rheumatol 2022; 51:513.</a></li><li><a class="nounderline abstract_t">Kawano Y, Kolstad KD, Li S, et al. Trends in adverse pregnancy outcomes among women with systemic sclerosis in the United States. Semin Arthritis Rheum 2023; 63:152252.</a></li><li><a class="nounderline abstract_t">Bellucci MJ, Coustan DR, Plotz RD. Cervical scleroderma: a case of soft tissue dystocia. Am J Obstet Gynecol 1984; 150:891.</a></li><li><a class="nounderline abstract_t">Stenchever MA, Ng AB. Scleroderma of the uterine cervix. Am J Obstet Gynecol 1970; 107:965.</a></li><li><a class="nounderline abstract_t">Ballou SP, Morley JJ, Kushner I. Pregnancy and systemic sclerosis. Arthritis Rheum 1984; 27:295.</a></li><li><a class="nounderline abstract_t">Deshauer S, Junek M, Baron M, et al. Effect of pregnancy on scleroderma progression. J Scleroderma Relat Disord 2023; 8:27.</a></li><li><a class="nounderline abstract_t">Traub YM, Shapiro AP, Rodnan GP, et al. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Medicine (Baltimore) 1983; 62:335.</a></li><li><a class="nounderline abstract_t">Black CM, Stevens WM. Scleroderma. Rheum Dis Clin North Am 1989; 15:193.</a></li><li><a class="nounderline abstract_t">Baethge BA, Wolf RE. Successful pregnancy with scleroderma renal disease and pulmonary hypertension in a patient using angiotensin converting enzyme inhibitors. Ann Rheum Dis 1989; 48:776.</a></li><li><a class="nounderline abstract_t">Karlen JR, Cook WA. Renal scleroderma and pregnancy. Obstet Gynecol 1974; 44:349.</a></li></ol></div><div id="topicVersionRevision">Topic 7558 Version 19.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Epidemiology of progressive systemic sclerosis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7760867" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Silicone breast implants and the risk of connective-tissue diseases and symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13208044" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Scleroderma; based on a study of over 150 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3382262" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1464871" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Reproductive function prior to disease onset in women with scleroderma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18975360" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Assessment of reproductive history in systemic sclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10211892" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Fertility and pregnancy outcome in women with systemic sclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3970741" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Pregnancy and systemic sclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2920051" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Pregnancy in women with systemic sclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31474594" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Pregnancy in Systemic Sclerosis: Results of a Systematic Review and Metaanalysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8849343" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Effects of immunosuppressive drugs during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22213060" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9031379" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Scleroderma and pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37738273" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Reproductive health in female patients with systemic sclerosis: a cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34637666" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Favourable outcome of planned pregnancies in systemic sclerosis patients during stable disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37666113" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Trends in adverse pregnancy outcomes among women with systemic sclerosis in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6507517" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Cervical scleroderma: a case of soft tissue dystocia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5429027" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Scleroderma of the uterine cervix.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6704193" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Pregnancy and systemic sclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36743807" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Effect of pregnancy on scleroderma progression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6355755" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2657888" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Scleroderma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2802801" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Successful pregnancy with scleroderma renal disease and pulmonary hypertension in a patient using angiotensin converting enzyme inhibitors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4854110" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Renal scleroderma and pregnancy.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
